Hormonal Support

Archival Status

The Hormonal Support protocol combines HCG (Human Chorionic Gonadotropin) and Kisspeptin to provide a research-based approach to maintaining hypothalamic-pituitary-testicular axis (HPTA) function — specifically in contexts where exogenous androgen or peptide use may suppress endogenous testosterone production. HCG is a glycoprotein hormone that binds with high affinity to the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) on Leydig cells in the testes. Its LH-mimetic action directly stimulates intratesticular testosterone (ITT) production and spermatogenesis, maintaining testicular volume and endocrine function. HCG is FDA-approved for cryptorchidism, hypogonadotropic hypogonadism, and fertility induction. In research contexts related to HPTA maintenance, low-dose HCG protocols (typically 250–500 IU every 2–3 days) are studied as a strategy to preserve testicular function during periods of LH suppression. Kisspeptin is a hypothalamic neuropeptide encoded by the KISS1 gene that acts as the master regulator of GnRH (gonadotropin-releasing hormone) secretion. It is the primary activator of the reproductive neuroendocrine axis — GnRH neurons require kisspeptin signaling through KISS1R to maintain pulsatile GnRH release, which drives pituitary LH and FSH secretion. Without adequate kisspeptin signaling, the hypothalamic component of the HPTA goes quiescent. Clinical studies demonstrate that kisspeptin administration restores LH pulsatility in men with HPTA suppression, making it a mechanistic upstream complement to HCG's downstream LH-receptor stimulation. The synergy between these two compounds addresses the HPTA at both ends: Kisspeptin restores hypothalamic GnRH drive (upstream), while HCG directly stimulates Leydig cell testosterone production (downstream). Together, they maintain the physiological function of the entire axis rather than bypassing it. Research applications include post-cycle HPTA recovery protocols, hypogonadotropic hypogonadism research, and fertility preservation studies. Both compounds require careful dosing and hormonal monitoring.